Patents-Review.com
ClassID:

117083 ⎘

C12Y304/24065 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Metalloendopeptidases (3.4.24) Macrophage elastase (3.4.24.65), i.e. metalloelastase

Recent Application in this class:
#1
20250066422
2025-02-27

IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER

 #2
20240182522
2024-06-06

IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER

 #3
20230365543
2023-11-16

MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF

 #4
20230014855
2023-01-19

MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF

 #5
20220298207
2022-09-22

Immunotherapy against several tumors including lung cancer

 #6
20220281917
2022-09-08

Immunotherapy against several tumors including lung cancer

 #7
20220194984
2022-06-23

Immunotherapy against several tumors including lung cancer

 #8
20220064220
2022-03-03

Immunotherapy against several tumors including lung cancer

 #9
20210253640
2021-08-19

Immunotherapy against several tumors including lung cancer

 #10
20210171509
2021-06-10

Matrix metalloproteinase (MMP) inhibitors and methods of use thereof

 #11
20200031870
2020-01-30

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #12
20200031869
2020-01-30

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #13
20200031868
2020-01-30

Immunotherapy against several tumors including lung cancer

 #14
20200031867
2020-01-30

Immunotherapy against several tumors including lung cancer

 #15
20200017551
2020-01-16

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #16
20190322703
2019-10-24

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #17
20190218254
2019-07-18

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #18
20190177369
2019-06-13

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #19
20190177368
2019-06-13

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #20
20190169233
2019-06-06

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #21
20190002504
2019-01-03

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #22
20170320913
2017-11-09

IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC

 #23
20170319675
2017-11-09

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #24
20170202937
2017-07-20

Immunotherapy against several tumors, such as lung cancer, including NSCLC

 #25
20160053250
2016-02-25

MATRIX METALLOPROTEINASSES AND USES THEREOF

 #26
20150079194
2015-03-19

Systems, compositions, and methods for transplantation and treating conditions

 #27
20120204274
2012-08-09

Transgenic mouse conditionally expressing MMP12 for studying myelopoiesis, immunity and tumorigenesis